MedTrace Logo

Cambridge Anti-Myopia Trial: Accommodation Training and Aberration Control in Myopia Development

NCT00317551 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2006-10-17

No results posted yet for this study

Summary

We have identified focussing problems related to myopia getting worse. Our trial uses optical and orthoptic interventions that correct the focussing problems to see if this retards myopia progression.

Conditions

  • Myopia

Interventions

DEVICE

Aberration controlled contact lens

BEHAVIORAL

Vision training

Sponsors & Collaborators

  • Vision CRC

    collaborator UNKNOWN

  • Anglia Ruskin University

    lead OTHER

Principal Investigators

  • Daniel J O'Leary, PhD · University of Wales Institute Cardiff

  • Peter M Allen, PhD · Anglia Ruskin University

  • Hema Radhakrishnan, PhD · University of Manchester

  • Richard I Calver, PhD · Anglia Ruskin University

  • Ebi P Osuobeni, PhD · Anglia Ruskin University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
14 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00317551 on ClinicalTrials.gov